Can Radiomics Analyses in <sup>18</sup>F-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

Araz, Mine; Soydal, Çigdem; Gündüz, Pinar; Kirmizi, Ayça; Bakirarar, Batuhan; Dizbay Sak, Serpil; Özkan, Elgin

Can Radiomics Analyses in ¹⁸F-FDG PET/CT Images of Primary Breast Carcinoma Predict Hormone Receptor Status?

Araz, Mine; Soydal, Çigdem; Gündüz, Pinar; Kirmizi, Ayça; Bakirarar, Batuhan; Dizbay Sak, Serpil; Özkan, Elgin.

Afiliación

Araz M; Ankara University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey.
Soydal Ç; Ankara University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey.
Gündüz P; Ankara University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey.
Kirmizi A; Ankara University Faculty of Medicine, Department of Pathology, Ankara, Turkey.
Bakirarar B; Ankara University Faculty of Medicine, Department of Biostatistics, Ankara, Turkey.
Dizbay Sak S; Ankara University Faculty of Medicine, Department of Pathology, Ankara, Turkey.
Özkan E; Ankara University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Turkey.

Mol Imaging Radionucl Ther ; 31(1): 49-56, 2022 Feb 02.

Article en En | MEDLINE | ID: mdl-35114752

Palabras clave

Breast cancer; PET/CT; fluorodeoxyglucose; hormone receptor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mol Imaging Radionucl Ther Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google